1,005
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Physician support of HPV vaccination school-entry requirements

, , , &
Pages 1626-1632 | Received 22 Oct 2015, Accepted 26 Jan 2016, Published online: 11 Apr 2016

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65:5-29; PMID:25559415; http://dx.doi.org/10.3322/caac.21254
  • De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol 2012; 13:607-15; PMID:22575588; http://dx.doi.org/10.1016/S1470-2045(12)70137-7
  • Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 2012; 5:18-23; PMID:22219162; http://dx.doi.org/10.1158/1940-6207.CAPR-11-0542
  • Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008; 113(10 SUPPL):3036-46; PMID:18980286; http://dx.doi.org/10.1002/cncr.23764
  • Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER, Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63:10; PMID:25167164
  • Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G, HPV Vaccine Study group. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006; 367:1247-55; PMID:16631880; http://dx.doi.org/10.1016/S0140-6736(06)68439-0
  • Markowitz E L, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 2013; 208:385-93; PMID:23785124; http://dx.doi.org/10.1093/infdis/jit192
  • Hariri S, Markowitz LE, Dunne EF, Unger ER. Population impact of HPV vaccines: Summary of early evidence. J Adolesc Health 2013; 53:679-82; PMID:24263069; http://dx.doi.org/10.1016/j.jadohealth.2013.09.018
  • Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009; 302:750-7; PMID:19690307; http://dx.doi.org/10.1001/jama.2009.1201
  • Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, MacNeil J, Markowitz LE, Stokley S. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:784-92; PMID:26225476; http://dx.doi.org/10.15585/mmwr.mm6429a3
  • Bugenske E, Stokley S, Kennedy A, Dorell C. Middle School Vaccination Requirements and Adolescent Vaccination Coverage. Pediatrics 2012; 129:1056-63; PMID:22566425; http://dx.doi.org/10.1542/peds.2011-2641
  • Hinman AR, Orenstein WA, Williamson DE, Darrington D. Childhood immunization: laws that work. J Law Med Ethics 2002; 30:122-127; PMID:12508514
  • Averhoff F, Linton L, Peddecord KM, Edwards C, Wang W, Fishbein D. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health 2004; 94:978-84; PMID:15249302; http://dx.doi.org/10.2105/AJPH.94.6.978
  • Briss PA, Rodewald LE, Hinman AR, Shefer AM, Strikas RA, Bernier RR, Carande-Kulis VG, Yusuf HR, Ndiaye SM, Williams SM. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med 2000; 18:92-6; PMID:10806981; http://dx.doi.org/10.1016/S0749-3797(99)00121-X
  • National Conference of State Legislatures. HPV vaccine: State legislation and statutes [Internet]. Washington DC: National Conference of State Legislatures; 2015. Retrieved from http://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx
  • Gilkey MB, Brewer NT. Mandatory HPV vaccination. JAMA 2012; 307:252-3; PMID:22253386; http://dx.doi.org/10.1001/jama.2011.2018
  • Smith JS, Brewer NT, Chang Y, Liddon N, Guerry S, Pettigrew E, Markowitz LE, Gottlieb SL. Acceptability of school requirements for human papillomavirus vaccine. Hum Vaccin 2011; 7:952-7; PMID:22024912; http://dx.doi.org/10.4161/hv.7.9.15995
  • Robitz R, Gottlieb SL, De Rosa CJ, Guerry SL, Liddon N, Zaidi A, Walker S, Smith JS, Brewer NT, Markowitz LE. Parent attitudes about school requirements for human papillomavirus vaccine in high-risk communities of Los Angeles, California. Cancer Epidemiol Biomarkers Prev 2011; 20:1421-9; PMID:21551243; http://dx.doi.org/10.1158/1055-9965.EPI-10-1236
  • Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines 2014; 13:235-46; PMID:24405401; http://dx.doi.org/10.1586/14760584.2013.871204
  • Brewer NT, Chung JK, Baker HM, Rothholz MC, Smith JS. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention. Gynecol Oncol 2014; 132 Suppl 1:S3-8; PMID:24361732; http://dx.doi.org/10.1016/j.ygyno.2013.12.020
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014; 168:76-82; PMID:24276343; http://dx.doi.org/10.1001/jamapediatrics.2013.2752
  • Lau M, Lin H, Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine 2012; 30:3112-8; PMID:22425179; http://dx.doi.org/10.1016/j.vaccine.2012.02.034
  • Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009; 69:475-80; PMID:19540642; http://dx.doi.org/10.1016/j.socscimed.2009.05.024
  • Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, Smith JS. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 2011; 38:197-204; PMID:20838362; http://dx.doi.org/10.1097/OLQ.0b013e3181f12dbf
  • Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ, Rosenthal SL. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: A statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009; 18:2325-32; PMID:19661092; http://dx.doi.org/10.1158/1055-9965.EPI-09-0184
  • Laugesen MJ, Paul RR, Luft HS, Aubry W, Ganiats TG. A comparative analysis of mandated benefit laws, 1949-2002. Health Serv Res 2006; 41:1081-1103; PMID:16704673; http://dx.doi.org/10.1111/j.1475-6773.2006.00521.x
  • Dempsey AF, Mendez D. Examining future adolescent human papillomavirus vaccine uptake, with and without a school mandate. J Adolesc Health 2010; 47:242-8; PMID:20708562; http://dx.doi.org/10.1016/j.jadohealth.2009.12.009
  • Moss JL, Reiter P, Young K, Brewer NT. Vaccination coverage, timeliness, and seasonality: Effect of states’ school entry requirements from 2007 to 2012. Under Rev
  • Haber G, Malow RM, Zimet GD. The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol 2007; 20:325-31; PMID:18082853; http://dx.doi.org/10.1016/j.jpag.2007.03.101
  • Kempe A, O'Leary ST, Kennedy A, Crane LA, Suh CA, Kennedy AM, Basket MM, Stokley SK, Dong F, Babbel CI, Seewald LA, Dickinson LM. Physician Response to Parental Requests to Spread Out the Recommended Vaccine Schedule. Pediatrics 2015; 135:666-77; PMID:25733753; http://dx.doi.org/10.1542/peds.2014-3474
  • Haenchen SD, Jacobs ET, Bratton KN, Carman AS, Oren E, Pottinger HL, Regan JA, Ernst KC. Perceptions of personal belief vaccine exemption policy: a survey of Arizona vaccine providers. Vaccine 2014; 32:3630-5; PMID:24814551; http://dx.doi.org/10.1016/j.vaccine.2014.04.081
  • McRee A-L, Gilkey MB, Dempsey AF. HPV vaccine hesitancy: findings from a statewide survey of health care providers. J Pediatr Health Care 2014; 28:541-9; PMID:25017939; http://dx.doi.org/10.1016/j.pedhc.2014.05.003
  • Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev 2009; 18:363-72; PMID:19190161; http://dx.doi.org/10.1158/1055-9965.EPI-08-0418
  • Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr 2011; 11:74; PMID:21878128; http://dx.doi.org/10.1186/1471-2431-11-74
  • Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, Halsey N, Giuliano AR. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011; 29:8634-41; PMID:21924315; http://dx.doi.org/10.1016/j.vaccine.2011.09.006
  • Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011; 29:890-5; PMID:20056186; http://dx.doi.org/10.1016/j.vaccine.2009.12.063
  • Howe M. Australian HPV vaccination programme yields results. Lancet Oncol 2014; 15:e591; PMID:25499291; http://dx.doi.org/10.1016/S1470-2045(14)71039-3
  • Mesher D, Soldan K, Howell-Jones R, Panwar K, Manyenga P, Jit M, Beddows S, Gill ON. Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England. Vaccine 2013; 32:26-32; PMID:24211166; http://dx.doi.org/10.1016/j.vaccine.2013.10.085
  • Colgrove J, Ph D, Abiola S, Mello MM, Ph D, Carolina S. HPV Vaccination Mandates — Lawmaking amid Political and Scientific Controversy. N Engl J Med 2010; 363:785-791; PMID:20818883; http://dx.doi.org/10.1056/NEJMsr1003547
  • GfK. KnowledgePanel Design Summary [Internet]. Palo Alto, CA: GfK; 2013. Retrieved from: http://www.knowledgenetworks.com/knpanel/docs/KnowledgePanel%28R%29-Design-Summary-Description.pdf
  • Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT. Physician communication about adolescent vaccination: How is human papillomavirus vaccine different? Prev Med 2015; 77:181-5; PMID:26051197; http://dx.doi.org/10.1016/j.ypmed.2015.05.024

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.